Everolimus is a medication that belongs to a class of drugs known as mTOR inhibitors. It works by blocking a specific protein that helps regulate cell growth and division, which can slow down or stop the growth of certain types of cancer cells. Everolimus is often used in the treatment of various cancers, including renal cell carcinoma and breast cancer, as well as in organ transplant patients to prevent rejection. In addition to its cancer-fighting properties, Everolimus is also used to treat tuberous sclerosis complex, a genetic disorder that can cause tumors in various organs. The medication is typically taken in pill form and is prescribed by healthcare professionals based on individual patient needs and conditions. Regular monitoring is essential to manage potential side effects and ensure the drug's effectiveness.